Trial · NCT03928184
Results by group20
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 20
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in OA Pain in the Target Knee (Pain NRS) | 0.07 mg Lorecivivint | -2.24 | Standard Error 0.13 | units on a scale | |
| Change From Baseline in OA Pain in the Target Knee (Pain NRS) | Vehicle | -2.49 | Standard Error 0.13 | units on a scale | |
| Change From Baseline in OA Pain in the Target Knee (Pain NRS) | 0.07 mg Lorecivivint | -2.42 | Standard Error 0.14 | units on a scale | |
| Change From Baseline in OA Pain in the Target Knee (Pain NRS) | Vehicle | -2.56 | Standard Error 0.13 | units on a scale | |
| Change From Baseline in OA Pain in the Target Knee (Pain NRS) | 0.07 mg Lorecivivint | -2.31 | Standard Error 0.14 | units on a scale | |
| Change From Baseline in OA Pain in the Target Knee (Pain NRS) | Vehicle | -2.47 | Standard Error 0.14 | units on a scale | |
| Change From Baseline in OA Function in the Target Knee (WOMAC Function) | 0.07 mg Lorecivivint | -21.87 | Standard Error 1.34 | units on a scale | |
| Change From Baseline in OA Function in the Target Knee (WOMAC Function) | Vehicle | -23.67 | Standard Error 1.34 | units on a scale | |
| Change From Baseline in OA Function in the Target Knee (WOMAC Function) | 0.07 mg Lorecivivint | -23.07 | Standard Error 1.42 | units on a scale | |
| Change From Baseline in OA Function in the Target Knee (WOMAC Function) | Vehicle | -23.93 | Standard Error 1.41 | units on a scale | |
| Change From Baseline in OA Function in the Target Knee (WOMAC Function) | 0.07 mg Lorecivivint | -22.08 | Standard Error 1.48 | units on a scale | |
| Change From Baseline in OA Function in the Target Knee (WOMAC Function) | Vehicle | -22.95 | Standard Error 1.48 | units on a scale | |
| Change From Baseline in OA Disease Activity (Patient Global Assessment) | 0.07 mg Lorecivivint | -25.26 | Standard Error 1.45 | units on a scale | |
| Change From Baseline in OA Disease Activity (Patient Global Assessment) | Vehicle | -25.89 | Standard Error 1.45 | units on a scale | |
| Change From Baseline in OA Disease Activity (Patient Global Assessment) | 0.07 mg Lorecivivint | -25.41 | Standard Error 1.50 | units on a scale | |
| Change From Baseline in OA Disease Activity (Patient Global Assessment) | Vehicle | -26.31 | Standard Error 1.50 | units on a scale | |
| Change From Baseline in OA Disease Activity (Patient Global Assessment) | 0.07 mg Lorecivivint | -23.79 | Standard Error 1.63 | units on a scale | |
| Change From Baseline in OA Disease Activity (Patient Global Assessment) | Vehicle | -24.76 | Standard Error 1.63 | units on a scale | |
| Change From Baseline in Medial Joint Space Width (mJSW) in the Target Knee | 0.07 mg Lorecivivint | -0.10 | Standard Error 0.03 | mm | |
| Change From Baseline in Medial Joint Space Width (mJSW) in the Target Knee | Vehicle | -0.07 | Standard Error 0.03 | mm |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03928184/results